Concepedia

Author

Andreas duBois

Charité - Universitätsmedizin Berlin

Also Known As

A DUBOIS, A Dubois, A duBois, A. DuBois, A. Dubois, A. duBois, Andreas duBois, Andreas durBois, DuBois, A., Dubois, A.

26

Publications

1.2K

Citations

12

H-Index

21

Concepts

All Affiliations

Charité - Universitätsmedizin BerlinInstitut Gustave RoussyCentre Antoine LacassagnePhilipps University of MarburgBC Cancer Agency
AD

About

Andreas duBois is an author at Charité - Universitätsmedizin Berlin specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

228

2

Obstetrics

2

2

99

3

Public Health

1

1

33

4

Genetic Medicine

1

1

33

5

Health Policy

1

1

33

Andreas duBois

×

11

Publications

695

Citations

10

H-Index

YearCitations

European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery

Denis Querleu, François Planchamp, Luis Chiva,

International Journal of Gynecological Cancer

2017

195

Vaccination of Patients with Advanced Ovarian Carcinoma with the Anti-Idiotype ACA125

Silke Reinartz, Siegmund Köhler, H. Schlebusch,

Clinical Cancer Research

2004

134

Incidence of Venous Thromboembolism in Patients With Ovarian Cancer Undergoing Platinum/Paclitaxel–Containing First-Line Chemotherapy: An Exploratory Analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group

Christina Fotopoulou, Andreas duBois, Alexandros N. Karavas,

Journal of Clinical Oncology

2008

91

Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum–taxane based therapy—A phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6)☆

U WAGNER, Andreas duBois, J. Pfisterer,

Gynecologic Oncology

2006

89

Activity of Pemetrexed (ALIMTA®, Multitargeted Antifolate, LY231514) in Metastatic Breast Cancer Patients Previously Treated with an Anthracycline and a Taxane: An Interim Analysis

M. Spielmann, Miguel Martín, Moïse Namer,

Clinical Breast Cancer

2001

49

Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines

Miguel Martín, M. Spielmann, M Namer,

Annals of Oncology

2003

47

Benefits, Issues, and Recommendations for Personalized Medicine in Oncology in Canada

Charles Butts, Suzanne Kamel‐Reid, Gerald Batist,

Current Oncology

2013

33

Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer.

Hans‐Joachim Lück, Christoph Thomssen, Andreas duBois,

PubMed

1996

23

Evaluation of Potentially Predictive Markers for Anti-Angiogenic Therapy with Sunitinib in Recurrent Ovarian Cancer Patients

Dirk Bauerschlag, Felix Hilpert, Werner Meier,

Translational Oncology

2013

12

Clinical course and management of paclitaxel extravasation

Andreas duBois, Martin Fehr, H Bochtler,

Oncology Reports

1996

12

Page 1